Patients with severe osteoporosis are now benefitting from the introduction of a new biological treatment at Hadassah Hospital Ein Kerem. The drug, given subcutaneously by injection, is an antibody that works against the protein inhibiting bone formation. Given once a month for up to a year, the drug has just entered the “drug basket” of 2020 and can be given to patients unable to receive Forteo, the only bone-building treatment previously available in Israel. To read the complete story, click here.
Medicine
Innovative Treatment for Osteoporosis Now Available at Hadassah Hospital
Other articles on the same subject
-
Hebrew U.: Large-Scale Study Finds Strong Connection Between Corona and Strokes – Particularly in Younger Patients
Read more -
Experimental Covid drug cures 30 out of 30 moderate to severe cases at Israeli hospital. Second new drug also shows promise.
Read more -
(Français) Covid-19 : à 70 ans, le Pr Andrew Kaye rempile au CHU Hadassah (Jérusalem, Israël)
Read more -
(Français) Hadassah, Kettura (Israël), IRD, Universités de Montpellier et Zurich… : des dattiers à partir de graines vieilles de 2000 ans
Read more -
Thyroid Cancer Diagnosis Enhanced at Hadassah Using Advanced Gene Sequencing
Read more -
A First in Israel: Cardiac Catheterization at Hadassah on 860-Gram Baby
Read more -
Hadassah (Israel) Surgeon Chosen to Participate in Gifted Citizen Event in Mexico City
Read more -
BGU Researchers Make Progress Towards a “Natural” Drug to Treat Osteoporosis
Read more -
Tel Aviv University and Hadassah: Changes to Specific MicroRNA Involved in Development of Lou Gehrig’s Disease
Read more -
Hadassah (Israel) doctors bring Humanitarian Surgery to Ethiopia
Read more